InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Mclaughlin Kevin F, Director. Officer active across 4 companies, notably Vericel Corp. In total, 20 disclosures have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €378k. History available since 23 September 2021. The latest transaction was disclosed on 12 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Mclaughlin Kevin F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
7,000 shares@ US$13.05Common StockSEC:0001140361-26-033143:0
7,000 shares@ US$44.53Common StockSEC:0001140361-26-033143:1
3,500 shares@ US$2.630.0005% mcap16.8% of flowCommon StockSEC:0001140361-26-021656:0
3,200 sharesCommon StockSEC:0001140361-26-018544:0
7,000 shares@ US$2.630.0009% mcap33.2% of flowCommon StockSEC:0001140361-26-005417:0
50,000 shares@ US$2.50100.0% of flowCommon StockSEC:0001193125-25-289825:0
Canonical exit: 17 Feb 2026 (T+90)
7,000 shares@ US$2.6311.7% of flowCommon StockSEC:0001140361-25-041647:0
7,000 shares@ US$2.7613.8% of flowCommon StockSEC:0001140361-25-029856:0
7,000 shares@ US$2.7613.4% of flowCommon StockSEC:0001140361-25-018156:0
3,200 sharesCommon StockSEC:0001140361-25-017117:0
6,000 shares@ US$3.7417.0% of flowCommon StockSEC:0001140361-25-004765:0
7,000 shares@ US$3.7419.4% of flowCommon StockSEC:0001140361-24-047070:0
5,000 shares@ US$3.7413.5% of flowCommon StockSEC:0001140361-24-036617:0
3,200 sharesCommon StockSEC:0001140361-24-024330:0
5,000 sharesCommon StockSEC:0000899243-23-019494:0
5,000 shares0Common StockSEC:0000950170-23-027990:0
2,600 sharesCommon StockSEC:0001140361-23-021500:0
2,600 sharesCommon StockSEC:0001593968-22-000890:0
10,681 sharesCommon StockSEC:0001104659-21-142266:0
2,500 shares@ US$30.17100.0% of flowCommon StockSEC:0001179110-21-008935:0
20 of 20 declarations
About Mclaughlin Kevin F
Kevin F. McLaughlin is a Director at Vericel Corp, Decibel Therapeutics, Inc. and Invivyd, Inc., and he was also SVP, CFO and Treasurer at Acceleron Pharma INC. Across 18 filings in total, the 18 sampled filings run from 2021-09-24 to 2026-05-15 and show EUR 107934 of buying and EUR 0 of selling, with option exercise as the transaction type.
